Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Ранг среди акций #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Цена акции
$0.00244926
Рыночная капитализация
$51.67K
Изменение (1 день)
5.88%
Изменение (1 год)
110.15%
Страна
GB
Торговля Nuformix plc (NFX)

Категория

Коэффициент P/B для Nuformix plc (NFX)
Коэффициент P/B на March 2026 TTM: 5.52
Согласно последним финансовым отчетам и цене акций Nuformix plc, текущий коэффициент P/B (TTM) составляет 5.52. В конце 2024 он составлял 0.64.
История P/B для Nuformix plc с 2014 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) 5.52 6.74%
2025 5.17 703.62%
2024 0.64 44.29%
2023 0.45 -63.79%
2022 1.23 -46.40%
2021 2.30 -42.90%
2020 4.02 28.15%
2019 3.14 93.67%
2018 1.62 -108.69%
2017 -18.66 -793.31%
2016 2.69 0.00%
2014 0.00 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
5.6573 2.51%
DK
6.3842 15.68%
US
2.4551 -55.51%
US
4.364 -20.92%
BE
2.5504 -53.79%
AU